Form 4: Encompass Health Director Receives Dividend-Linked RSUs

Director Nancy M. Schlichting acquired 39 restricted stock units as part of a dividend reinvestment program.

Summary

• Director Nancy M. Schlichting was credited with 39 additional restricted stock units (RSUs) on April 15, 2026.
• The acquisition resulted from the company's dividend payment of $0.19 per share, with the RSUs calculated based on a closing price of $105.24.
• Following this transaction, the director's total beneficial ownership stands at 21,298 shares of Encompass Health common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine disclosure of director equity holdings related to dividend payments.

Positives

• Reflects alignment of director interests with shareholders through dividend-linked equity accumulation.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable.

Industry Context

StockSavvy.ai notes that this is a routine administrative transaction common among corporate directors, indicating standard dividend reinvestment practices rather than a change in strategic outlook.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices for non-employee director compensation and dividend treatment.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity adjustment for a director.

Key Dates

Keywords

Encompass Health, EHC, Form 4, Insider Transaction, Restricted Stock Units, Dividend Reinvestment